Welcome to IdahoLifeScience.com

This network addresses the growing informational and service needs of companies, patients, educators and others in their respective states while providing clients the opportunity to cost effectively advertise their job openings, events, facility availability and other services at the state level, regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting services.

Learn about Seattle's Icogenex Biotech Incubator

Learn about biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in Idaho, regionally or nationwide.

Industry News...

Free News Release Posting & Archiving Service


• U.S. to provide antiviral medication to Latin America and the Caribbean for H1N1 influenza  HHS Secretary Kathleen Sebelius announced that the United States will provide 420,000 treatment courses of Tamiflu (Oseltamavir) to the Pan-American Health Organization (PAHO) to fight the novel H1N1 influenza in Latin America and the Caribbean.
  Dept. of Health & Human Services  July 02, 2009  
  
  
• Oncolytics Biotech completes patient enrolment in U.K. REOLYSIN(R) trial  Oncolytics Biotech announced that patient enrolment has been completed in the Phase II component of a Phase I/II U.K. trial of REOLYSIN combined with paclitaxel/carboplatin for patients with advanced cancers.
  Oncolytics Biotech Inc.  July 02, 2009  
  
  
• FDA approves Multaq to treat heart rhythm disorder  The U.S. Food and Drug Administration has approved Multaq tablets (dronedarone) to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter (heart rhythm disorders).
  FDA  July 02, 2009  
  
  
• Johnson & Johnson and Elan Corporation announce definitive agreement  Johnson & Johnson and Elan Corporation announced a definitive agreement whereby Johnson & Johnson will acquire substantially all of the assets and rights of Elan related to its Alzheimer's Immunotherapy Program (AIP Program), through a newly formed company.
  Johnson & Johnson  July 02, 2009  
  
  
• Graceway Pharmaceuticals acquires early-stage dermatological molecules from Pfizer  Graceway Pharmaceuticals and Pfizer announced that they have entered into an Acquisition and License Agreement by which Graceway will acquire worldwide commercial rights for three investigational dermatological molecules from Pfizer and the related transferred or licensed intellectual properties.
  Pfizer Inc.  July 01, 2009  
  
  

More... | Submit News Release | Advertising...

New Job Postings...

Free Job Posting Trial Offer

• Project Manager l Seattle Biomedical Research Institute (SBRI) (WA)
• Microbiologist, Environmental Monitoring LabTemps (WA)
• Senior Clinical Research Associate Gilead Sciences (WA)
• Clinical Trial Coordinator, Technology Solutions PATH (WA)
• Research Associate I or II Institute for Systems Biology (WA)

More... | Job Advertising... | About Job Postings...

New Facilities Available...

ATC clean room constructors...validation guaranteed!

• 890 Embarcadero Road Property -- West Sacramento, CA
• Icogenex Biotech Incubator -- Seattle, WA
• Life Sciences Incubator -- Seattle, WA
• University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
• University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA

More... | Facility Advertising...

Upcoming Events...

ORCA Monthly Meeting - July 9: Register now!

• 07/05/2009: Darwin Anniversary Festival
• 07/07/2009: Information Session: OHSU Graduate Programs in Healthcare Management
• 07/07/2009: Alliance of Angels 10-Minute Pitch Clinic
• 07/09/2009: ORCA Monthly Meeting: FDA Updates (. . . Will the Elephant Dance Again?)
• 07/12/2009: IAFP 2009 - 96th Annual Meeting

More... | Submit Event | Event Advertising...